There has been a recent increase in availability of banked donor milk for feeding of preterm infants. This milk is pooled from donations to milk banks from carefully screened lactating women. The milk is then pasteurized by the Holder method to remove all microbes. The processed milk is frozen, banked, and sold to neonatal intensive care units (NICUs). The nutrient bioavailability of banked donor milk has been described, but little is known about preservation of immune components such as cytokines, chemokines, and growth factors (CCGF).
Objective:
The objective was to compare CCGF in banked donor milk with mother’s own milk (MOM).
Methods:
Aliquots (0.5 mL) were collected daily from MOM pumped by 45 mothers of NICU-admitted infants weighing < 1500 grams at birth. All daily aliquots of each mother’s milk were pooled each week during 6 weeks of an infant’s NICU stay or for as long as the mother provided MOM. The weekly pooled milk was measured for a panel of CCGF through multiplexing using magnetic beads and a MAGPIX instrument. Banked donor milk samples (n = 25) were handled and measured in the same way as MOM.
Results:
Multiplex analysis revealed that there were levels of CCGF in banked donor milk samples comparable to values obtained from MOM after 6 weeks of lactation.
Conclusion:
These data suggest that many important CCGF are not destroyed by Holder pasteurization.
The American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827-e841.
2.
PerrineCGScanlonKS. Prevalence of use of human milk in US advanced care neonatal units. Pediatrics. 2013;131(6):1066-1071.
3.
UpdegroveK. Nonprofit human milk banking in the United States [published online July 29, 2013]. J Midwifery Womens Health. doi:10.1111/j.1542-2011.2012.00267.x.
4.
EdwardsTMSpatzDL. Making the case for using donor human milk in vulnerable infants. Adv Neonatal Care. 2012;12(5):273-278; quiz 279-280.
5.
EwaschukJBUngerSHarveySO’ConnorDLFieldCJ. Effect of pasteurization on immune components of milk: implications for feeding preterm infants. Appl Physiol Nutr Metab. 2011;36(2):175-182.
6.
McPhersonRJWagnerCL. The effect of pasteurization on transforming growth factor alpha and transforming growth factor beta 2 concentrations in human milk. Adv Exp Med Biol. 2001;501:559-566.
7.
BragaLPPalharesDB. Effect of evaporation and pasteurization in the biochemical and immunological composition of human milk. J Pediatr (Rio J). 2007;83(1):59-63.
8.
ChristenLLaiCTHartmannPE. Ultrasonication and the quality of human milk: variation of power and time of exposure. J Dairy Res. 2012;79(3):361-366.
9.
Espinosa-MartosIMontillaAde SeguraAG. Bacteriological, biochemical, and immunological modifications in human colostrum after Holder pasteurisation. J Pediatr Gastroenterol Nutr. 2013;56(5):560-568.
10.
UntalanPBKeeneySEPalkowetzKHRiveraAGoldmanAS. Heat susceptibility of interleukin-10 and other cytokines in donor human milk. Breastfeed Med. 2009;4(3):137-144.
11.
GoelzRHihnEHamprechtK. Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. Pediatr Res. 2009;65(4):458-461.
12.
ReevesAAJohnsonMCVasquezMMMaheshwariABlancoCL. TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk. Breastfeed Med. 2013;8(6):496-502.
13.
EwaschukJBUngerSO’ConnorDL. Effect of pasteurization on selected immune components of donated human breast milk. J Perinatol. 2011;31(9):593-598.
14.
OddyWH. The impact of breastmilk on infant and child health. Breastfeed Rev. 2002;10(3):5-18.
15.
GarofaloR. Cytokines in human milk. J Pediatr. 2010;156(suppl 2):S36-S40.
16.
NewburgDSWalkerWA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res. 2007;61(1):2-8.
17.
SullivanSSchanlerRJKimJH. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562-567.
18.
SchanlerRJShulmanRJLauC. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics. 1999;103(6, pt 1):1150-1157.
19.
VohrBRPoindexterBBDusickAM. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics. 2007;120(4):e953-e959.
20.
Ramirez-SantanaCPerez-CanoFJAudiC. Effects of cooling and freezing storage on the stability of bioactive factors in human colostrum. J Dairy Sci. 2012;95(5):2319-2325.
21.
ChattertonDENguyenDNBeringSBSangildPT. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol. 2013;45(8):1730-1747.
22.
Espinosa-MartosIMontillaASeguraAG. Bacteriological, biochemical, and immunological modifications in human colostrum after holder pasteurisation. J Pediatr Gastroenterol Nutr. 2013;56(5):560-568.
23.
GroerMKaneBWilliamsS. Multiplexing of human preterm and term cytokines. Poster presented at: Experimental Biology Conference; April 21, 2013; Boston, MA.
24.
HeimanHSchanlerRJ. Benefits of maternal and donor human milk for premature infants. Early Hum Dev. 2006;82(12):781-787.
25.
MenonGWilliamsTC. Human milk for preterm infants: why, what, when and how?Arch Dis Child Fetal Neonatal Ed. 2013;98(6):F559-F562.
26.
ArnoldLD. The cost-effectiveness of using banked donor milk in the neonatal intensive care unit: prevention of necrotizing enterocolitis. J Hum Lact. 2002;18(2):172-177.
27.
JegierBJJohnsonTJEngstromJLPatelALLoeraFMeierP. The institutional cost of acquiring 100 mL of human milk for very low birth weight infants in the neonatal intensive care unit. J Hum Lact. 2013;29(3):390-399.
28.
SharmaRHudakML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol. 2013;40(1):27-51.
29.
UstundagBYilmazEDoganY. Levels of cytokines (IL-1β, IL-2, IL-6, IL-8, TNF-α) and trace elements (Zn, Cu) in breast milk from mothers of preterm and term infants. Mediators Inflamm. 2005;2005(6):331-336.
30.
KverkaMBurianovaJLodinova-ZadnikovaR. Cytokine profiling in human colostrum and milk by protein array. Clin Chem. 2007;53(5):955-962.
31.
HawkesJSBryanDLJamesMJGibsonRA. Cytokines (IL-1beta, IL-6, TNF-alpha, TGF-beta1, and TGF-beta2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatr Res. 1999;46(2):194-199.
32.
CastelloteCCasillasRRamirez-SantanaC. Premature delivery influences the immunological composition of colostrum and transitional and mature human milk. J Nutr. 2011;141(6):1181-1187.
33.
BauerJGerssJ. Longitudinal analysis of macronutrients and minerals in human milk produced by mothers of preterm infants. Clin Nutr. 2011;30(2):215-220.
34.
JangSHLeeBSParkJH. Serial changes of fatty acids in preterm breast milk of Korean women. J Hum Lact. 2011;27(3):279-285.
35.
ZanardoVNicolussiSCarloG. Beta endorphin concentrations in human milk. J Pediatr Gastroenterol Nutr. 2001;33(2):160-164.
36.
DelfosseNMWardLLagomarcinoAJ. Donor human milk largely replaces formula-feeding of preterm infants in two urban hospitals. J Perinatol. 2013;33(6):446-451.
